Luciferase enzymes for use with thermostable luciferins in bioluminescent assays
Provided herein are enhanced luciferase enzymes for use with thermostable luciferin analogs for bioluminescent assays. In particular, the present disclosure provides compositions, assays, and methods for performing a bioluminescent assay using enhanced, high-activity luciferase enzymes compatible with thermostable luciferins, such as 5,5-disubstituted luciferin analogs.
1 . A luciferase polypeptide capable of producing an increased bioluminescent signal in the presence of a 5,5-disubstituted luciferin compared to a bioluminescent signal produced by a luciferase polypeptide of SEQ ID NO: 1 in the presence of the 5,5-disubstituted luciferin, wherein the luciferase polypeptide is not naturally occurring and comprises at least 90% sequence identity with the amino acid sequence of SEQ ID NO: 2, and less than 100% sequence identity with the amino acid sequence of SEQ ID NO: 1, wherein the polypeptide comprises at least one amino acid substitution at position 109, 218, 236, 240, 254, 300, 305, 335, 339, 344, and 396 relative to the amino acid sequence of SEQ ID NO: 1.
2 . The luciferase polypeptide of claim 1 , wherein the at least one amino acid substitution is selected from 1109M, F218L, 1236V, 1240L, Y254S, V300G, L305F, L305P, V335G, Y339M, T344A, and 1396K, and/or any conservative or semi-conservative variations of the at least one amino acid substitution.
3 . The luciferase polypeptide of claim 1 , wherein the at least one amino acid substitution is selected from 1240L, Y254S, T344A, and 1396K relative to the amino acid sequence of SEQ ID NO: 1, and/or any conservative or semi-conservative variations of the amino acid substitutions.
4 . The luciferase polypeptide of claim 1 , wherein the at least one amino acid substitution is selected from V300G, and 1396K relative to the amino acid sequence of SEQ ID NO: 1, and/or any conservative or semi-conservative variations of the amino acid substitutions.
5 . The luciferase polypeptide of claim 1 , wherein the at least one amino acid substitution is selected from T344A, 1396K, V300G, and L305P relative to the amino acid sequence of SEQ ID NO: 1, and/or any conservative or semi-conservative variations of the amino acid substitutions.
6 . The luciferase polypeptide of claim 1 , wherein the at least one amino acid substitution is selected from L305F, 1109V, and V335G-relative to the amino acid sequence of SEQ ID NO: 1, and/or any conservative or semi-conservative variations of the amino acid substitutions.
7 . The luciferase polypeptide of claim 1 , wherein the at least one amino acid substitution is selected from 1109M, L305F, Y339M, T344A, and 1396K relative to the amino acid sequence of SEQ ID NO: 1, and/or any conservative or semi-conservative variations of the amino acid substitutions.
8 . The luciferase polypeptide of claim 1 , wherein at least one amino acid substitution is selected from 1109M, L305P, Y339M, T344A, and 1396K relative to amino acid sequence of SEQ ID NO: 1, and/or any conservative or semi-conservative variations of the amino acid substitutions.
9 . The luciferase polypeptide of claim 1 , wherein the polypeptide is resistant to inhibition by dehydroluciferin and derivatives thereof compared to inhibition of the luciferase polypeptide of the amino acid sequence of SEQ ID NO: 1 by the dehydroluciferin and derivatives thereof.
10 . The luciferase polypeptide of claim 1 , wherein the bioluminescent signal produced by the luciferase polypeptide is increased at least 10-fold compared to the bioluminescent signal produced by the luciferase polypeptide of the amino acid sequence of SEQ ID NO: 1.
11 . A reagent composition for a bioluminescent assay, the composition comprising the luciferase polypeptide of claim 1 , and a substrate for the luciferase polypeptide.
12 . The reagent composition of claim 11 , wherein the substrate for the luciferase polypeptide is racemic luciferin.
13 . The reagent composition of claim 11 , wherein the substrate for the luciferase polypeptide is 5,5-disubstituted luciferin.
14 . The reagent composition of claim 11 , wherein the reagent composition further comprises one or more additional components selected from the group consisting of: a buffer, a defoamer, an ATPase inhibitor, L-luciferin, azathiothymine, an enzyme stabilizer, a detergent, an inhibitor of ATP-generating enzymes, a lysing agent, an ATP-extraction agent, co-enzyme A, a thiol reagent, a metal ion chelator, a protease inhibitor, pyrophosphate, sodium fluoride, dehydroluciferin, and a salt.
15 . A kit comprising the reagent composition of claim 11 .
16 . An assay system for detecting or quantifying ATP in a sample, the system comprising:
a reagent composition comprising the luciferase polypeptide of claim 1 , a 5,5-disubstituted luciferin; and a sample comprising or suspected of comprising ATP.